Immunic, Inc. (IMUX) — Financial statements
Income statement, balance sheet, and cash flow for Immunic, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 82↑2.4% | 80↓3.8% | 83↑16.8% | 71↑16.6% | 61 | |
| General & Administrative Expenses | 21↑18.0% | 18↑12.5% | 16↑4.9% | 15↑14.8% | 13 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 21↑18.0% | 18↑12.5% | 16↑4.9% | 15↑14.8% | 13 | |
| Other Expenses | 0.00 | 0.00 | 0.00↓100.0% | 33↑91.1% | 17 | |
| Operating Expenses | 103↑5.3% | 98↓1.2% | 99↓17.0% | 119↑30.4% | 92 | |
| Total Costs & Expenses | 103↑5.3% | 98↓1.2% | 99↓17.0% | 119↑30.4% | 92 | |
| Operating Results | ||||||
| Operating Income | -103↓5.3% | -98↑1.2% | -99↑17.0% | -119↓30.4% | -92 | |
| Depreciation & Amortization | 0.17↑25.4% | 0.13↑20.7% | 0.11↑44.2% | 0.08↓9.4% | 0.09 | |
| EBITDA | -103↓5.3% | -98↑1.2% | -99↓14.7% | -86↑5.6% | -92 | |
| EBIT | -103↓5.3% | -98↑1.2% | -99↓14.7% | -87↑5.6% | -92 | |
| Interest & Other Income | ||||||
| Net Interest Income | 1↓69.3% | 3↑10.2% | 3 | 0.00↓100.0% | 0.07 | |
| Interest Income | 1↓69.3% | 3↑10.2% | 3↑195.4% | 1↑1477.3% | 0.07 | |
| Interest Expense | 0.00 | 0.00 | 0.00↓100.0% | 1 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00↑100.0% | -33 | 0.00 | |
| Other Income / Expenses | 6↑346.7% | -2↓143.8% | 6↑710.6% | -0.92↑28.2% | -1 | |
| Income Before Tax | -97↑3.3% | -101↓7.4% | -94↑22.3% | -120↓29.5% | -93 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -97↑3.3% | -101↓7.4% | -94↑22.3% | -120↓29.5% | -93 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -97↑3.3% | -101↓7.4% | -94↑22.3% | -120↓29.5% | -93 | |
| Bottom-Line Net Income | -97↑3.3% | -101↓7.4% | -94↑22.3% | -120↓29.5% | -93 | |
| EPS (Basic) | -6.24↑37.6% | -10.00↑52.6% | -21.10↑44.2% | -37.80↑3.6% | -39.20 | |
| EPS (Diluted) | -6.24↑37.6% | -10.00↑52.6% | -21.10↑44.2% | -37.80↑3.6% | -39.20 | |
| Weighted Average Shares | 16↑55.4% | 10↑126.0% | 4↑39.3% | 3↑34.5% | 2 | |
| Weighted Average Diluted Shares | 16↑55.4% | 10↑126.0% | 4↑39.3% | 3↑34.5% | 2 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.